Abilify® Gambling Addiction Lawsuits
In May 2016, the FDA issued an official warning about impulse-control problems related to use of the drug Abilify®.
“The U.S. Food and Drug Administration (FDA) is warning that compulsive or uncontrollable urges to gamble, binge eat, shop, and have sex have been reported with the use of the antipsychotic drug aripiprazole (Abilify®, Abilify Maintena®, Aristada, and generics).”
FDA Safety Alerts
Patients and caregivers should be on alert for uncontrollable and excessive urges and behaviors while taking aripiprazole.
These after-effects of Abilify® were enough to warrant multiple lawsuits filed against Bristol-Myers Squibb and Otsuka America Pharmaceuticals for failing to list all possible side effects of the drug.
Abilify® lawsuits have been filed against the Abilify® manufacturers by both patients and their families seeking compensation for injuries, including the severe emotional damage caused by this drug and these side effects.
Doctors issue 8.7 MILLION prescriptions of Abilify® a year, and this number is growing.